BioCardia director granted 8,000 stock options
BioCardia director Marvin Slosman received a stock option grant for 8,000 shares of common stock on the reported date.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
BioCardia director Marvin Slosman received a stock option grant for 8,000 shares of common stock on the reported date. The option has an exercise price of $1.20 per share and expires on July 6, 2036, bringing his directly held stock options to 20,000 shares. All 8,000 option shares vest and become exercisable on the one-year anniversary of the grant, provided he continues as a service provider through that date.
Insider Trade Summary
Grant/Award: 8,000 shares
Grant/Award
1 txn
Insider
Slosman Marvin
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 8,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 20,000 contracts (Direct)
Footnotes (1)
- F1. One hundred percent of the shares are subject to the option vesting and becoming exercisable on the one-year anniversary of the date of grant, subject to the Reporting Person continuing as a service provider through such date.
Key Figures
Options granted: 8,000 options
Exercise price: $1.20 per share
Total options after grant: 20,000 options
+2 more
5 metrics
Options granted
8,000 options
Stock option grant reported on Form 4
Exercise price
$1.20 per share
Strike price for newly granted options
Total options after grant
20,000 options
Derivative securities owned following transaction
Expiration date
July 6, 2036
Option expiry for the 8,000-share grant
Vesting schedule
100% after one year
Cliff vesting conditioned on continued service
Key Terms
Stock Option (right to buy), exercise price, vesting, service provider, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 1.2000"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"shares are subject to the option vesting and becoming exercisable"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
service provider financial
"subject to the Reporting Person continuing as a service provider"
derivative securities financial
"derivativeTransactionCount: 1"
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did BioCardia (BCDA) director Marvin Slosman report?
Director Marvin Slosman reported receiving a grant of 8,000 stock options. These options give him the right to buy BioCardia common shares at a fixed price, subject to vesting after one year of continued service.
What is the exercise price of Marvin Slosman’s new BioCardia (BCDA) stock options?
The new stock options have an exercise price of $1.20 per share. This means Slosman can buy BioCardia common stock at $1.20 once the options vest and before they expire in 2036, regardless of future market prices.
When do Marvin Slosman’s newly granted BioCardia (BCDA) options vest?
All 8,000 option shares vest on the one-year anniversary of the grant date. Vesting is conditional on Slosman continuing as a service provider to BioCardia through that date, after which the options become exercisable.
How many BioCardia (BCDA) stock options does Marvin Slosman hold after this Form 4?
Following this grant, Slosman directly holds stock options covering 20,000 shares of BioCardia common stock. The filing shows the total derivative securities owned after the transaction, including the newly granted 8,000 options.
What is the expiration date of Marvin Slosman’s new BioCardia (BCDA) stock options?
The granted stock options expire on July 6, 2036. Slosman must wait for vesting after one year to exercise them and must do so before the 2036 expiration date, or the right to purchase shares lapses.
AI-generated analysis. How Rhea-AI works. Not financial advice.
